trial
as of 2026-07-01Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component
NCTId NCT01466439
at a glance
Phase 2 · Completed
Enrollment 30 (actual)
Sponsored by University Hospital, Caen
Primary completion 2012-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2011-05
Primary completion
2012-06
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
University Hospital, CaenLead Sponsor
Investigators
1
Pr Sonia Dollfus, MD, PhDPrincipal Investigator
Sites
1 total
Caen, France
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
30
Phase
PHASE2
Primary Completion Date
2012-06
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
investigator